KEYNOTE-061: phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer.
Shitara, K Özgüroğlu, M Bang, Y Di Bartolomeo, M Mandalà, M Ryu, M Fornaro, L Olesiński, T Caglevic, C Chung, H
Shitara, K
Özgüroğlu, M
Bang, Y
Di Bartolomeo, M
Mandalà, M
Ryu, M
Fornaro, L
Olesiński, T
Caglevic, C
Chung, H
Citations
Altmetric:
Abstract
Description
Date
2018-06
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
KEYNOTE-061: phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer. 2018, 29(suppl_5): Ann Oncol